Breaking News

Financial Report: BioClinica 3Q

November 8, 2012

Service revenues reach a record $19.2 million

BioClinica

3Q Revenues: $24.9 million (+16%)

3Q Earnings: $542,000 (+51%)

YTD Revenues: $70.7 million (+15%)

YTD Earnings: $2.6 million (+57%)

Comments: Service revenues increased 16% to a record $19.2 million. Current backlog was $114.1 million, up 4% in the quarter. Mark L. Weinstein, president and chief executive officer of BioClinica said, “We are extremely pleased with our third quarter operating results, which included strong growth in service revenue and non-GAAP operating income and margin resulting from increased demand for both our eClinical and medical imaging offerings.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks